- 商品介绍
- 规格参数
- 包装参数
Application
The pharmacodynamics profile of SB 222200 enables its use as a tool to study physiological and pathophysiological roles of NK-3 receptor in CNS-modulated behaviors.
Biochem/physiol Actions
Non-peptide NK3 tachykinin receptor antagonist.
SB 222200 is a 2-phenyl-4-quinolinecarboxamides and a selective, reversible and competitive antagonist of human NK-3 receptor that effectively crosses the blood-brain barrier. It inhibits the NK-3 receptor-induced miosis or pupil constriction in conscious rabbits.1,2
Features and Benefits
This compound was developed by GlaxoSmithKline. To browse the list of other pharma-developed compounds and Approved Drugs/Drug Candidates, click here.
Legal Information
Sold for research purposes under agreement from GlaxoSmithKline
| Quality Level | 100 |
| assay | ≥98% (HPLC) |
| form | solid |
| color | light yellow |
| solubility | DMSO: soluble ~28 mg/mL,H2O: insoluble |
| originator | GlaxoSmithKline |
| storage temp. | 2-8°C |
| SMILES string | CC[C@H](NC(=O)c1c(C)c(nc2ccccc12)-c3ccccc3)c4ccccc4 |
| InChI | 1S/C26H24N2O/c1-3-22(19-12-6-4-7-13-19)28-26(29)24-18(2)25(20-14-8-5-9-15-20)27-23-17-11-10-16-21(23)24/h4-17,22H,3H2,1-2H3,(H,28,29)/t22-/m0/s1 |
| InChI key | MQNYRKWJSMQECI-QFIPXVFZSA-N |
| Gene Information | human ... TACR2(6865), TACR3(6870) |
| 长度(mm) | |
| 宽度(mm) | |
| 高度(mm) | |
| 重量(kg) |
-
询价
-
¥ 2290.21
-
¥ 1683.78
-
询价
-
¥ 2019.57
-
询价
-
询价
-
¥ 3152.47
-
¥ 6330.00
-
¥ 3812.28
-
无菌，PETG 方形有刻度培养基瓶，带盖，聚对苯二酸乙二醇酯共聚物，天然高密度聚乙烯盖，500毫升容量，每箱40，40/箱，342020-0500，Nalgene，Thermofisher，赛默飞世尔¥ 3684.34
-
询价
-
¥ 1196.00
-
¥ 1749.15
-
¥ 3031.24
-
¥ 5804.96
-
询价
-
¥ 4614.63
-
询价
-
¥ 70526.15
微信小程序
7X24小时在线咨询